Clinical features of invasive fungal disease in children with no underlying disease

被引:0
作者
Juan Huang
Chentao Liu
Xiangrong Zheng
机构
[1] Central South University,Department of Pediatrics, Xiangya Hospital
[2] The First Hospital of Changsha,Department of Pediatric
来源
Scientific Reports | / 12卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
There is limited research into Invasive fungal disease (IFD) in children with no underlying disease. We undertook a retrospective study of children with IFD who did not suffer from another underlying disease, from June 2010 to March 2018 in Changsha, China. Nine children were identified. Eosinophil counts were elevated in six cases. The level of procalcitonin (PCT) was elevated in six cases. Fungal culture was positive in all patients, including eight cases of Cryptococcus neoformans and one case of Candida parapsilosis. 8.33 days following antifungal treatment, the body temperature of the eight patients affected by cryptococcal disease had returned to normal. Our study indicates that the primary pathogen in IFD was Cryptococcus neoformans in children who had no other underlying disease. Eosinophils can be considered to be indicators of cryptococcal infection. IFD in children with no other underlying disease has a satisfactory prognosis.
引用
收藏
相关论文
共 61 条
[1]  
von Lilienfeld-Toal M(2019)Invasive fungal infection Deutsches Arzteblatt Int. 116 271-278
[2]  
Wagener J(2018)Epidemiology and clinical features of invasive fungal infection in a US health care network Open Forum Infect. Dis. 5 187-390
[3]  
Einsele H(2016)An estimation of burden of serious fungal infections in France Jo. Mycol. Med. 26 385-71
[4]  
Cornely OA(2017)Estimating the burden of invasive and serious fungal disease in the United Kingdom J. Infect. 74 60-11
[5]  
Kurzai O(2016)The global burden of fungal diseases Infect. Dis. Clin. N. Am. 30 1-1821
[6]  
Webb BJ(2012)Hidden killers: human fungal infections Sci. Transl. Med. 4 165113-322
[7]  
Gangneux JP(2008)Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group Clin. Infect. Dis. 46 1813-214
[8]  
Pegorie M(2010)Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america Clin. Infect. Dis. 50 291-307
[9]  
Denning DW(2013)Mortality predictors of bloodstream infections in solid-organ transplant recipients Exp. Clin. Transpl. 11 211-S21
[10]  
Welfare W(2013)The risk factors for mortality in deceased donor liver transplant recipients with bloodstream infections Transpl. Proc. 45 305-137